European pharma stocks fall after Trump slaps 100% tariffs on medicine imports

European pharma stocks fall after Trump slaps 100% tariffs on medicine imports


Stocks listed in Europe were broadly higher on Friday, as investors assessed the latest trade policy announcements out of the White House.

The pan-European Stoxx 600 index was up by 0.2% by around 10:00 a.m. London time (5 a.m. ET), with most sectors in positive territory.

The Stoxx Europe 600 Healthcare index saw rocky trade in the morning, oscillating above and below the flatline. It was last seen trading 0.2% lower.

Overnight, President Donald Trump announced that pharmaceutical imports to the U.S. would be hit with 100% tariffs from Oct. 1. Companies who built manufacturing facilities in America would be exempt, Trump said, but only once they started breaking ground on the construction of U.S. plants.

Previously, Trump had threatened to impose tariffs of up to 200% on pharma imports.

Denmark’s Zealand Pharma was last seen down 2.5%, while Novo Nordisk and Finland’s Orion were also trading more than 2% lower on Friday morning.

However, in a note circulated in the wake of Trump’s announcements, JP Morgan strategists downplayed the impact the new tariffs would have on the pharmaceutical sector.

The “potential 100% tariff should largely be avoidable with us based manufacturing buildout,” they said. “And while there remain a number of unknowns on tonight’s announcement … we continue to see a very manageable overall impact from tariffs to our large cap coverage.”

Trump also announced on his Truth Social platform on Thursday night that heavy trucks would be slapped with 25% tariffs from next month.

The European Union’s own trade policies are also in focus, after German newspaper Handelsblatt reported that the bloc was planning to impose tariffs of up to 50% on Chinese steel in the coming weeks.

On Thursday, European stocks closed lower following the Trump administration’s launch of a national security probe into medical device imports, which could pave the way for further tariffs.

Overnight in Asia, pharma stocks notched losses as investors reacted to the looming U.S. tariffs on the sector.

In terms of economic data, Friday will see the release of Spain’s latest inflation print, U.K. mortgage lending figures, and a report on European economic sentiment.



Source

U.S. to remove tariffs on some products from Ecuador, Argentina, Guatemala and El Salvador
World

U.S. to remove tariffs on some products from Ecuador, Argentina, Guatemala and El Salvador

The United States said Thursday it will remove tariffs on some foods and other imports from Argentina, Ecuador, Guatemala and El Salvador under framework agreements that will give U.S. firms greater access to those markets. The agreements are expected to help lower prices for coffee, bananas and other foodstuffs, a senior Trump administration official told […]

Read More
Asia-Pacific shares set to fall, tracking Wall Street declines as tech selloff deepens
World

Asia-Pacific shares set to fall, tracking Wall Street declines as tech selloff deepens

Tourists visit the Nanjing Road Scenic Area in Shanghai, China, on October 20, 2025. Nurphoto | Nurphoto | Getty Images Asia-Pacific markets were set to open lower on Friday, tracking losses on Wall Street as technology stocks continued to come under pressure. Japan’s benchmark Nikkei 225 index was set for a lower open, with its […]

Read More
Tesla recalls 10,500 Powerwall 2 battery systems due to overheating, fire risk
World

Tesla recalls 10,500 Powerwall 2 battery systems due to overheating, fire risk

Tesla’s Powerwall 2 Source: Tesla Tesla is recalling around 10,500 units of its Powerwall 2, a backup battery for residential use, according to a U.S. Consumer Product Safety Commission disclosure out Thursday. “The lithium-ion battery cells in certain Powerwall 2 systems can cause the unit to stop functioning during normal use, which can result in […]

Read More